Fintel reports that on April 2, 2025, BTIG initiated coverage of NRx Pharmaceuticals (NasdaqCM:NRXP) with a Buy ...

BTIG initiated coverage of NRx Pharmaceuticals (NRXP) with a Buy rating and $18 price target NRx Pharmaceuticals is working broadly in ...

Fintel reports that on March 31, 2025, BTIG upgraded their outlook for Progyny (NasdaqGS:PGNY) from Neutral to Buy. Analyst ...

BTIG analysts highlighted a historical trend suggesting a potential rebound for the S&P 500 (SPX) in April following a ...

BTIG says Rocket Companies (RKT) is acquiring Mr. Cooper (COOP) in an all-stock deal valuing Cooper at roughly $143 ore share, plus a $2 cash ...

The S&P 500's recent breakdown below key technical levels suggests the market’s counter-trend rally may be over, said ...

Lululemon Athletica (NASDAQ:LULU – Free Report) had its price objective decreased by BTIG Research from $470.00 to $420.00 in ...

U.S. equities mostly gained at midday on continued optimism about tariffs and a solid increase in home prices.

Shares of cybersecurity company CrowdStrike (NASDAQ:CRWD) jumped 5.2% in the morning session after BTIG upgraded the stock's ...

Shares of CrowdStrike (NASDAQ: CRWD) surged higher on Monday. The move up comes as the S&P 500 and Nasdaq Composite had ...

Investing.com -- BTIG raised its CrowdStrike (NASDAQ: CRWD) stock rating to Buy from Neutral on Tuesday, pointing to improved ...

(Reuters) - Wall Street's main indexes were prepared to open slightly higher on Tuesday as investors assessed implications of ...